Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas.

J Sperveslage, M Hoffmeister, T Henopp, G Klöppel, B Sipos
Author Information
  1. J Sperveslage: Institute of Pathology, University of Tübingen, Liebermeisterstr.8, 72076, Tübingen, Germany, jan.sperveslage@med.uni-tuebingen.de.

Abstract

There is need to determine tissue-specific robust controls for normalization of microRNA expression to avoid false results and misinterpretation. The aim of this study was to evaluate the expression of different small RNAs in neuroendocrine tumors (NETs) and their suitability as normalizers in miRNA real-time PCR experiments. We investigated the expression of the nine small RNAs miR-93, miR-191, SNORD48, SNORD61, SNORD68, SNORD72, SNORD95, SNORD96a, and RNU6-2 in formalin-fixed, paraffin-embedded tissue samples of 25 ileal NETs by real-time PCR determining the most stable controls for expression normalization using four different algorithms. This analysis was expended to ten pancreatic NETs. Finally, five small RNAs were further tested as normalizers for miRNA-133a expression, which is known to be downregulated in metastases of ileal NETs, in ten matched pairs of ileal NETs and their metastases. Ranking of the expression results revealed the following order of stability from high to low: SNORD61 < SNORD95 < SNORD72 < SNORD96a < SNORD68 < miR-191 < miR-93 < RNU6-2 < SNORD48 for ileal NETs and SNORD95 < miR-93 < SNORD96a < SNORD61 < SNORD68 < SNORD72 < RNU6-2 < miR-191 < SNORD48 for pancreatic NETs. The determination of SNORD61 and SNORD95 for ileal NETs and SNORD95 and miR-93 for pancreatic NETs as good normalizers presents a useful tool for experiments involving the analysis of miRNA expression.

References

  1. Nature. 2007 Oct 11;449(7163):682-8 [PMID: 17898713]
  2. PLoS One. 2012;7(8):e43452 [PMID: 22912877]
  3. Cell Rep. 2013 Aug 15;4(3):437-44 [PMID: 23933255]
  4. Mod Pathol. 2010 Mar;23(3):367-75 [PMID: 20037573]
  5. Dig Dis Sci. 2012 Apr;57(4):897-904 [PMID: 22198701]
  6. PLoS One. 2012;7(8):e42978 [PMID: 22900072]
  7. PLoS One. 2013;8(1):e55044 [PMID: 23383050]
  8. BMC Mol Biol. 2006 Oct 06;7:33 [PMID: 17026756]
  9. Exp Oncol. 2012;34(1):2-8 [PMID: 22453141]
  10. Cancer Res. 2004 Aug 1;64(15):5245-50 [PMID: 15289330]
  11. Genome Biol. 2002 Jun 18;3(7):RESEARCH0034 [PMID: 12184808]
  12. Biotechnol Lett. 2004 Mar;26(6):509-15 [PMID: 15127793]
  13. Exp Mol Med. 2010 Nov 30;42(11):749-58 [PMID: 20890088]
  14. PLoS One. 2012;7(2):e31060 [PMID: 22347428]
  15. RNA. 2008 May;14(5):844-52 [PMID: 18375788]
  16. PLoS One. 2013;8(3):e59390 [PMID: 23527180]

MeSH Term

Gene Expression Profiling
Humans
Ileal Neoplasms
MicroRNAs
Neuroendocrine Tumors
Pancreatic Neoplasms
Real-Time Polymerase Chain Reaction

Chemicals

MicroRNAs

Word Cloud

Created with Highcharts 10.0.0<NETsexpressionSNORD95ilealmiR-93SNORD61controlsnormalizationsmallRNAsnormalizersmiRNAmiR-191SNORD48SNORD68SNORD72SNORD96aRNU6-2pancreaticrobustresultsdifferentneuroendocrinetumorsreal-timePCRexperimentsanalysistenmetastasesneeddeterminetissue-specificmicroRNAavoidfalsemisinterpretationaimstudyevaluatesuitabilityinvestigatednineformalin-fixedparaffin-embeddedtissuesamples25determiningstableusingfouralgorithmsexpendedFinallyfivetestedmiRNA-133aknowndownregulatedmatchedpairsRankingrevealedfollowingorderstabilityhighlow:determinationgoodpresentsusefultoolinvolvingEstablishmentileumpancreas

Similar Articles

Cited By